ANI PHARMACEUTICALS INC
StreetZero Signal 57
About ANI PHARMACEUTICALS INC
ANI Pharmaceuticals, Inc. is a public pharmaceutical manufacturing company headquartered in Princeton, New Jersey, United States. It operates a B2B business model and has been listed on NASDAQ under ticker ANIP since its 2013 IPO. The company focuses on in-licensing, acquiring businesses, technologies, products or assets while funding commercialization efforts including sales, marketing and general corporate purposes.
LATEST FUNDINGRule 144
$386K
Announced 2026-11-16
TOTAL RAISED$582M
IN THE NEWS
- ๐ ANI Pharmaceuticals, Inc.
- ๐ ANI Pharmaceuticals, Inc. Company Overview, Contact Details & Competitors | LeadIQ
- ๐ ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock - ANI Pharmaceuticals, Inc.
- ๐ ANI Pharmaceuticals - 2026 Company Profile, Funding, Competitors & Financials - Tracxn
- ๐ ANI Pharmaceuticals - 2026 Company Profile, Funding, Competitors & Financials - Tracxn
EMPLOYEES501-1000
FOUNDED1999
HQPrinceton, New Jersey, United States
Industry
Public Equity (NASDAQ)
Tags
Pharmaceutical ManufacturingPublic CompanyB2BNASDAQ
Investors
Key highlights
- Completed $306.8M Post-IPO Debt round in August 2024
- IPO on NASDAQ in June 2013 under ticker ANIP
- Revenue range reported as $500M-$1B
- Headcount approximately 600
- Underwritten public offering of common stock announced in May 2023
Ask StreetZero about ANI PHARMACEUTICALS INC
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account